Eton Pharmaceuticals (ETON) Institutional Ownership
13F filers reported holding 69.9% of Eton Pharmaceuticals (ETON) shares as of Jun 30, 2026, across 164 filers.
4 figures withheld by our checks. Each blank figure names its reason.
- Held by 13F filers
- 69.9%
- Jun 30, 2026
- 13F filers
- 164
- quarter ended Jun 30, 2026
- 13F value
- $730.2M
- 20.2M shares
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | CASAMENTO CHARLES J | director | Acquired · Option exercise | 12,500 | $7.31 | ↗ |
| Nov 10, 2026 | CASAMENTO CHARLES J | director | Acquired · Option exercise | 27,400 | $3.58 | ↗ |
| Nov 10, 2026 | CASAMENTO CHARLES J | director | Acquired · Option exercise | 19,655 | $8.61 | ↗ |
| Nov 10, 2026 | CASAMENTO CHARLES J | director | Acquired · Option exercise | 21,000 | $3.78 | ↗ |
| Nov 10, 2026 | CASAMENTO CHARLES J | director | Disposed · Open-market sale | 6,380 | $64.33 | ↗ |
| Nov 10, 2026 | CASAMENTO CHARLES J | director | Disposed · Open-market sale | 14,715 | $65.32 | ↗ |
| Nov 10, 2026 | CASAMENTO CHARLES J | director | Disposed · Open-market sale | 22,601 | $66.26 | ↗ |
| Nov 10, 2026 | CASAMENTO CHARLES J | director | Disposed · Open-market sale | 33,956 | $67.11 | ↗ |
| Nov 10, 2026 | CASAMENTO CHARLES J | director | Disposed · Open-market sale | 2,903 | $67.87 | ↗ |
| Nov 10, 2026 | CASAMENTO CHARLES J | director | Disposed · Option exercise | 12,500Stock Option | — | ↗ |
| Nov 10, 2026 | CASAMENTO CHARLES J | director | Disposed · Option exercise | 27,400Stock Option | — | ↗ |
| Nov 10, 2026 | CASAMENTO CHARLES J | director | Disposed · Option exercise | 19,655Stock Option | — | ↗ |
| Nov 10, 2026 | CASAMENTO CHARLES J | director | Disposed · Option exercise | 21,000Stock Option | — | ↗ |
| Oct 6, 2026 | Krempa David | Chief Business Officer | Disposed · Open-market sale | 4,166 | $55.07 | ↗ |
| Oct 2, 2026 | Krempa David | Chief Business Officer | Acquired · Option exercise | 10,522 | — | ↗ |
| Oct 2, 2026 | Krempa David | Chief Business Officer | Disposed · Option exercise | 10,522Restricted Stock Units | — | ↗ |
| Aug 28, 2026 | MAIER PAUL V | director | Acquired · Option exercise | 50,000 | $3.78 | ↗ |
| Aug 28, 2026 | MAIER PAUL V | director | Disposed · Open-market sale | 36,387 | $58.64 | ↗ |
| Aug 28, 2026 | MAIER PAUL V | director | Disposed · Open-market sale | 13,485 | $60.21 | ↗ |
| Aug 28, 2026 | MAIER PAUL V | director | Disposed · Open-market sale | 128 | $61.77 | ↗ |
* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Eton Pharmaceuticals do institutions hold?
13F filers reported holding 69.9% of Eton Pharmaceuticals' shares as of Jun 30, 2026, across 164 filers.
How many 13F filers hold Eton Pharmaceuticals?
Eton Pharmaceuticals was held by 164 13F filers as of Jun 30, 2026.
Not investment advice.

